Echocardiographic screening for rheumatic heart disease

Circulation

Volumn 129, Issue 19, 2014, Pages 1912-1913

  Tani, Lloyd Y ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; Editorials; Mass screening; Rheumatic fever; Rheumatic heart disease

Indexed keywords

PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; AUSTRALIA; CARDIOLOGIST; DISEASE COURSE; ECHOCARDIOGRAPHY; EDITORIAL; HISTORY; HUMAN; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RHEUMATIC HEART DISEASE; SCREENING; SENSITIVITY AND SPECIFICITY;

ECHOCARDIOGRAPHY; EDITORIALS; MASS SCREENING; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

FEMALE; HUMANS; MALE; MASS SCREENING; POPULATION GROUPS; RHEUMATIC HEART DISEASE;

EID: 84901505775     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009406     Document Type: Editorial

References (20)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-694.
2. Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ. 1995;73:583-587.
3. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation. 2013;128:492-501.
4. Carapetis JR, Currie BJ, Mathews JD. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect. 2000;124:239-244.
5. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
6. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease: T. Duckett Jones Memorial Lecture. Circulation. 1985;72:1155-1162.
7. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser. 2004;923:1-122, back cover.
8. Chang C. Cutting edge issues in rheumatic fever. Clin Rev Allergy Immunol. 2012;42:213-237.
9. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM; World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10:284-292.
10. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J Am Med Assoc. 1950;143:151-153.
11. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119:1541-1551.
12. Irlam J, Mayosi BM, Engel M, Gaziano TA. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6:343-351.
13. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 1994;124:9-16.
14. Manji RA, Witt J, Tappia PS, Jung Y, Menkis AH, Ramjiawan B. Cost- effectiveness analysis of rheumatic heart disease prevention strategies. Expert Rev Pharmacoecon Outcomes Res. 2013;13:715-724.
15. Spagnuolo M, Pasternack B, Taranta A. Risk of rheumatic-fever recurrences after streptococcal infections: prospective study of clinical and social factors. N Engl J Med. 1971;285:641-647.
16. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri VI, Wheaton G, Zühlke L, Carapetis J. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease: an evidence-based guideline. Nat Rev Cardiol. 2012;9:297-309.
17. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470-476.
18. Carapetis JR, Hardy M, Fakakovikaetau T, Taib R, Wilkinson L, Penny DJ, Steer AC. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med. 2008;5:411-417.
19. Roberts K, Maguire G, Brown A, Atkinson D, Remenyi B, Wheaton G, Kelly A, Kumar RK, Su J-Y, Carapetis JR. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014;129:1953-1961.
20. Parnaby MG, Carapetis JR. Rheumatic fever in indigenous Australian children. J Paediatr Child Health. 2010;46:527-533.